11:10 AM EDT, 05/14/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were edging lower late Wednesday morning, down 0.3% at 1,413.61 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies ( DBVT ) and semiconductor company Sequans Communications ( SQNS ) , which climbed 15% and 9.8% respectively. They were followed by accommodations booking company trivago (TRVG) and financial services company Banco Bilbao Vizcaya Argentaria ( BBVA ) , which increased 3.7% and 1.6% respectively.

The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and biopharmaceutical company Grifols ( GRFS ) , which dropped 4.6% and 3.4% respectively. They were followed by telecommunications operator Telefonica ( TEF ) and pharmaceutical company Ascendis Pharma ( ASND ) , which lost 2.3% and 1.7% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company NuCana ( NCNA ) and biotech firm Trinity Biotech ( TRIB ) , which advanced 25% and 5.9% respectively. They were followed by biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) and financial services company Lloyds Banking Group ( LYG ) , which were up 3.2% and 1.7% respectively.

The decliners from the UK and Ireland were led by software firm Endava ( DAVA ) and biotech company Autolus Therapeutics ( AUTL ) , which fell 27% and 3.5% respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group ( MREO ) and Amarin ( AMRN ) , which were down 3.2% and 1.5% respectively.